Product Images Dofetilide

This is a table showing the mean change from baseline QTc (in milliseconds) at various plasma dofetilide concentrations (in ng/mL).*

The text appears to be displaying medication doses in milligrams ("meg") and results from a Log Rank Test. The medication being tested is "Dofetiide" at doses of 125mg, 250mg, and 500mg twice a day. The p-values for each dose are also displayed. The text also includes a "Placebo" group and a chart showing time in months. It is unclear what "ing in NSR" at the beginning means.*

This appears to be a graph that shows survival rates in relation to dosage of a medication. There are three dosages represented (125 meg BID, 250 meg BID, and 500 mog BID). The y-axis measures the probability of remaining in NSR (normal sinus rhythm) and ranges from 0 to 1. The x-axis shows time in months (ranging from 0 to 12) and there are markers at 6 and 9 months. The graph includes a p-value log rank test that indicates statistically significant differences in survival rates between the three dosage groups (p=0.006 for 125 meg BID, p<0.001 for 250 mog BID, and p<0.001 for 500 mog BID).*

The text is providing instructions for medical professionals to follow when administering dofetilide to patients. It includes steps to ensure the drug is safe for use, and recommended dosages based on the patient's calculated creatinine clearance. The text also describes when and how to adjust the dosage based on QTc or QT measurements, and when to discontinue the drug altogether.*

This is a medication description for Dofetilide capsules. Each capsule contains 125mcg (0.125mg) of Dofetilide, USP. The package insert contains complete prescribing information, and the capsules should be stored at 20°C to 25°C. They must be protected from moisture and humidity and dispensed in tight, light-resistant containers as defined in the USP, with child-resistant closure. Manufactured by Mayne Pharma, these capsules are only for distribution by pharmacists and accompanied by medication guides.*

This is a description of a medication called Dofetilide. It comes in capsule form with 250mcg (0.250mg) of the active ingredient per capsule. The recommended dosage can be found in the package insert which contains complete prescribing information. The medication should be stored between 20°C and 25°C (68°F to 77°F) and protected from moisture and humidity. The capsules should be dispensed in a light resistant container with a child-resistant closure. It is manufactured by Mayne Pharma in Greenville,NC and comes in a 60 capsule package. Pharmacist should dispense the medication guide to each patient.*

This is a prescription medication called Dofetilide that comes in capsule form. Each capsule contains 500 micrograms (0.500 mg) of Dofetilide, USP. Patients should follow the instructions included in the package insert for complete prescribing information. The capsules should be stored at a temperature between 20°C and 25°C (68°F to 77°F) and protected from moisture and humidity. It should be dispensed in a tight, light-resistant container as defined by the United States Pharmacopeia (USP) with a child-resistant closure. The medication guide should be provided to each patient along with the capsules. This medication is manufactured by Mayne Pharma and comes in a package of 60 capsules.*